G2GBIO
Latest round
- Series B
Last raised
- Jul 2020
Total raised
- $16M
Investors
- 10
About G2GBIO
Based in Cheongju, South Korea, and founded in 2017, G2GBIO, Inc. specializes in the development and manufacturing of innovative injectable drug formulations, focusing on sustained-release microsphere injectables to enhance cancer treatment efficacy. G2GBIO, Inc. develops advanced injectable drug formulations. In March 2026, Samsung Epis Holdings agreed to acquire convertible bonds in G2GBIO, Inc. at KRW 116,900 apiece for KRW 20 billion, in a PIPE transaction. The deal is expected to be completed at the end of the month. The CEO is Hee-yong Lee. G2GBIO, Inc. specializes in the development and manufacturing of injectable drug formulations, particularly focusing on sustained-release microsphere injectables. Their key products include the InteLAMP technology, which enables prolonged release of therapeutics from microspheres and promotes uniform distribution within tumor tissues, effectively targeting and eliminating cancer cells. Their offerings cater to a global client base, including pharmaceutical companies and healthcare providers in markets such as South Korea, Japan, and the broader Asian region, addressing various medical conditions through advanced drug delivery systems. G2GBIO, Inc. generates revenue through strategic partnerships with global pharmaceutical companies for the production and supply of proprietary injectable formulations. Revenue transactions involve contracts for manufacturing sustained-release injectable drugs, with pricing based on customized solutions for client specifications and market needs. The company will use the March 2026 funds for its operations.
Who invested in G2GBIO
10 investors across 2 rounds
See all investors in G2GBIO
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about G2GBIO
Who invested in G2GBIO?
G2GBIO has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has G2GBIO raised?
G2GBIO has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did G2GBIO last raise money?
G2GBIO's most recent round on record is a Series B, in Jul 2020.
What does G2GBIO do?
Based in Cheongju, South Korea, and founded in 2017, G2GBIO, Inc.
Where is G2GBIO headquartered?
G2GBIO is headquartered in Cheongju-si, South Korea.
Which VCs invest in companies like G2GBIO?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at G2GBIO's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like G2GBIO? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.